JP2023520794A5 - - Google Patents

Info

Publication number
JP2023520794A5
JP2023520794A5 JP2022560311A JP2022560311A JP2023520794A5 JP 2023520794 A5 JP2023520794 A5 JP 2023520794A5 JP 2022560311 A JP2022560311 A JP 2022560311A JP 2022560311 A JP2022560311 A JP 2022560311A JP 2023520794 A5 JP2023520794 A5 JP 2023520794A5
Authority
JP
Japan
Prior art keywords
compound
propa
tetrahydro
biphenyl
diol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022560311A
Other languages
English (en)
Japanese (ja)
Other versions
JP7714571B2 (ja
JP2023520794A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2021/050812 external-priority patent/WO2021198692A1/en
Publication of JP2023520794A publication Critical patent/JP2023520794A/ja
Publication of JP2023520794A5 publication Critical patent/JP2023520794A5/ja
Application granted granted Critical
Publication of JP7714571B2 publication Critical patent/JP7714571B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022560311A 2020-03-31 2021-03-31 テルペンフェノール化合物およびそれらの使用 Active JP7714571B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063003270P 2020-03-31 2020-03-31
US63/003,270 2020-03-31
PCT/GB2021/050812 WO2021198692A1 (en) 2020-03-31 2021-03-31 Terpenophenolic compounds and their use

Publications (3)

Publication Number Publication Date
JP2023520794A JP2023520794A (ja) 2023-05-19
JP2023520794A5 true JP2023520794A5 (enExample) 2024-04-11
JP7714571B2 JP7714571B2 (ja) 2025-07-29

Family

ID=75426633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022560311A Active JP7714571B2 (ja) 2020-03-31 2021-03-31 テルペンフェノール化合物およびそれらの使用

Country Status (11)

Country Link
US (2) US12552733B2 (enExample)
EP (1) EP4126800A1 (enExample)
JP (1) JP7714571B2 (enExample)
KR (1) KR20230121960A (enExample)
CN (1) CN116194431B (enExample)
AU (1) AU2021248627A1 (enExample)
BR (1) BR112022019616A2 (enExample)
GB (3) GB2628746A (enExample)
IL (1) IL296861A (enExample)
MX (1) MX2022011832A (enExample)
WO (1) WO2021198692A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3959193A4 (en) * 2019-05-23 2022-07-13 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136839A (en) * 2000-06-16 2006-12-10 Yissum Res Dev Co Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same
EP2578561A1 (en) 2005-09-29 2013-04-10 Albany Molecular Research, Inc. Processes for the production of cannabidiol derivatives and intermediates thereof
AU2012201041B2 (en) * 2005-09-29 2012-12-06 Albany Molecular Research, Inc. Process for production of delta-9-tetrahydrocannabinol
DK2176208T3 (en) * 2007-07-30 2015-04-27 Zynerba Pharmaceuticals Inc Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof
DE102009019322A1 (de) 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
TWI583374B (zh) * 2010-03-30 2017-05-21 Gw伐瑪有限公司 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途
WO2014177593A1 (en) 2013-04-29 2014-11-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Amorfrutin analogs as ppargamma-modulators
US9526706B1 (en) 2015-06-16 2016-12-27 Hong Kong Baptist University Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury
US9738581B2 (en) * 2015-06-16 2017-08-22 Hong Kong Baptist University Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions
US20170008869A1 (en) * 2015-07-10 2017-01-12 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
CN109311838A (zh) 2016-04-15 2019-02-05 蒂温诺特技术有限公司 大麻素前药的生物合成
US20170362195A1 (en) 2016-06-16 2017-12-21 Full Spectrum Laboratories Ltd Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use
US10640482B2 (en) 2017-07-21 2020-05-05 University Of South Florida Synthesis of cannabinoids
CN111372907A (zh) 2017-09-01 2020-07-03 普优峰全球股份有限公司 合成大麻二酚组合物和用于制备其的方法
DE102017008367B4 (de) * 2017-09-06 2019-06-13 Sumitomo Wiring Systems, Ltd. Abschirmverbinder und Verfahren zum Zusammenbauen desselben
EP3840854A4 (en) * 2018-08-20 2022-06-29 Bessor Pharma, LLC Novel cannabinoids and cannabinoid acids and their derivatives
EP3959193A4 (en) * 2019-05-23 2022-07-13 Kare Chemical Technologies Inc. Catalytic cannabinoid processes and precursors
CA3150642A1 (en) * 2019-09-09 2021-03-18 Kamaluddin Abdur-Rashid CANNABINOID DERIVATIVES, PRECURSORS AND USES
CA3150646A1 (en) * 2019-09-10 2021-03-18 Kamaluddin Abdur-Rashid CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRICAL SYNTHESIS THEREOF

Similar Documents

Publication Publication Date Title
TWI335217B (en) Pharmaceutical formulations of modafinil
AU2020239746B2 (en) Compositions comprising methylphenidate-prodrugs, processes of making and using the same
JP2006522747A5 (enExample)
JP2002523452A (ja) 肺疾患の治療方法
CN102159077A (zh) 用于治疗神经性疼痛的方法
US12128012B2 (en) Ketamine treatment for amyotrophic lateral sclerosis
US20130296413A1 (en) N-desmethyl-doxepin and methods of using the same to treat sleep disorders
MX2010013312A (es) Tratamientos novedoos.
CN102307836B (zh) 用于治疗疼痛的化合物
JP2005531612A (ja) ネフォパムの製剤および痛みの治療におけるその使用
CA2422901A1 (en) Use of tolterodine to treat asthma
GB2609814A (en) Terpenophenolic compounds and their use
WO2018107131A1 (en) Methylphenidate-prodrugs, processes of making and using the same
CN101507726B (zh) 窦房结If电流抑制剂和β-阻滞剂的组合
US6194466B1 (en) Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
JP2022518288A5 (enExample)
JP2025505578A5 (enExample)
JP2004002474A (ja) 純粋なフルオキセチンのs(+)異性体を用いる組成物
KR20060023997A (ko) 신경보호 약제 조성물을 제조하기 위한바이시클로〔2.2.1〕헵탄 유도체의 용도
JP2023515612A5 (enExample)
CN103570669A (zh) 脑靶向o-去甲基文拉法辛酚酯类前药及制备方法和用途
CN114080221B (zh) 用于减轻疼痛的布洛芬与曲马多的组合
CN115252583B (zh) 复方盐酸替利定缓释制剂及其制备方法
JP4888751B2 (ja) トリフルオロプロピルアミノペンタン誘導体及びその製造方法
JP2004538305A (ja) 3−ヘテロシクリル−及び3−シクロアルキル−3−アリールオキシプロパンアミンによる慢性疼痛の治療